July 31st, 2009, by David Pascoe | clinical trials, doxium, laser therapy, pulse dye laser
A new trial is recruiting participants to evaluate the use of calcium dobelisate as a combination therapy, along with Pulse Dye Laser to treat the erythema, flushing and telangectasia associated with erythematotelangietatic rosacea. We know from rosacea and doxium that “Calcium dobesilate is a vasoactive drug with presumed effects on endothelial integrity, capillary permeability and blood viscosity.” Clinical Trial …
June 3rd, 2009, by David Pascoe | clinical trials, doxium, research
Thanks to a comment from Sophie on the post rosacea and doxium (calcium dobesilate) we know that Dr. Cuevas who is responsible for several papers on Dobesilate, is accepting people to try it as a treatment for rosacea. Thanks for the info Sophie. Calcium dobesilate (2,5-dihydroxybenzene sulfonate) is a vasoactive drug with presumed effects on endothelial integrity, capillary permeability and blood viscosity. It …
January 1st, 2006, by David Pascoe | doxium, research
Calcium dobesilate is a vasoactive drug with presumed effects on endothelial integrity, capillary permeability and blood viscosity. It is often recommended for venous disorders, and also prescribed for diabetic retinopathy and other microvascular disorders. (from http://www.wallace.co.in/productbrochures/dobest-II.pdf)
Therapeutic response of rosacea to dobesilate, European Journal Medical Research. 2005 Oct 18;10(10):454-6., Cuevas P, Arrazola JM., Department …
|
|
|
|
|
|
|
|
 |